| Literature DB >> 26530543 |
Miek Hornikx1, Heleen Demeyer2, Carlos Augusto Camillo3, Wim Janssens4, Thierry Troosters5.
Abstract
BACKGROUND: In some patients with COPD, the disease is characterized by exacerbations. Severe exacerbations warrant a hospitalization, with prolonged detrimental effects on physical activity. Interventions after an exacerbation may improve physical activity, with longstanding health benefits. Physical activity counseling and real-time feedback were effective in stable COPD. No evidence is available on the use of this therapeutic modality in patients after a COPD exacerbation.Entities:
Mesh:
Year: 2015 PMID: 26530543 PMCID: PMC4632467 DOI: 10.1186/s12890-015-0126-8
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Fig. 1Consort diagram of the study
Fig. 2Study protocol
Baseline characteristics
| Control group ( | Intervention group ( |
| |
|---|---|---|---|
| Demographic characteristics | |||
| Age (years) | 68 ± 6 | 66 ± 7 | 0.34 |
| BMI (kg/m2) | 29 ± 5 | 25 ± 9 | 0.20 |
| Gender (male (N (%)) | 9 (60) | 8 (53) | 0.71 |
| Pulmonary function | |||
| FEV1 (% predicted) | 48 ± 18 | 38 ± 17 | 0.11 |
| Tiffeneau Index (%) | 47 ± 13 | 41 ± 14 | 0.28 |
| Peripheral muscle strength | |||
| QF (Nm) | 112 ± 28 | 84 ± 42 | 0.05 |
| QF (% predicted) | 85 ± 43 | 71 ± 38 | 0.38 |
| Functional exercise capacity | |||
| 6MWD (meter) | 317 ± 95 | 235 ± 134 | 0.07 |
| 6MWD (% predicted) | 53 ± 16 | 36 ± 18 | 0.01 |
| Stops during 6MWD (amount) | 0.66 ± 0.62 | 1.23 ± 0.92 | 0.15 |
| Duration of stops (s) | 38 ± 48 | 81 ± 61 | 0.08 |
| Physical activity | |||
| PAsteps (amount/day) | 1557 ± 1319 | 1644 ± 2751 | 0.93 |
| PAwalk (minutes/day) | 20 ± 17 | 22 ± 35 | 0.90 |
| PAint (m/s2) | 1.34 ± 0.50 | 1.46 ± 0.25 | 0.50 |
| Questionnaires | |||
| mMRC (points) | 2 [2–3] | 3 [2–3] | 0.39 |
| CAT (points) | 19 [15–22] | 25 [13–28] | 0.42 |
BMI body mass index, FEV forced expiratory volume in 1 s, QF quadriceps strength, 6MWD six minutes walking distance, PAsteps daily amount of steps, PAwalk daily walking time, PAint movement Intensity during walking, mMRC modified medical research council dyspnea scale, CAT COPD assessment test. Data are expressed as mean ± SD, median [IQR] or as N (%). p < 0.05
Fig. 3Changes in physical activity during 1 month in the 2 study groups, measured by the Dynaport MoveMonitor
Change in physical activity during 1 month measured by the Dynaport MoveMonitor
| Control group ( | Intervention group ( | |
|---|---|---|
| ΔPAsteps (amount/day) | ||
| Time effect ( | 1013 ± 1275 | 984 ± 1208 |
| ΔPAwalk (minutes/day) | ||
| Time effect ( | 13 ± 14 | 13 ± 16 |
| ΔPAint (m/s2/day) | ||
| Time effect ( | 0.08 ± 0.06 | 0.06 ± 0.05 |
PAsteps daily amount of steps, PAwalk daily walking time, PAint movement Intensity during walking, Data are expressed as mean ± SD p < 0.05
Fig. 4Day-by-day pattern in PAsteps measured by the Fitbit Ultra® during the intervention period
Change in clinical parameters during 1 month
| Control group ( | Intervention group ( |
| |
|---|---|---|---|
| Muscle strength | |||
| ΔQF (Nm) | 0.4 ± 20 | 5.3 ± 12 | 0.48 |
| Functional exercise capacity | |||
| Δ6MWD (meter) | 64 ± 59 | 67 ± 84 | 0.93 |
| ΔStops during 6MWD (amount) | 0.08 ± 1.16 | 0.18 ± 1.08 | 0.84 |
| ΔDuration of stops (s) | −14 ± 52 | −18 ± 57 | 0.86 |
| Questionnaires | |||
| ΔmMRC (points) | 0 [−1 to 0] | 0 [−1 to 0] | 0.93 |
| ΔCAT (points) | −5 [−7 to 1] | −3 [−10 to 1] | 0.78 |
QF quadriceps strength, 6MWD six minutes walking distance, mMRC modified medical research council dyspnea scale, CAT COPD assessment test. Data are expressed as mean ± SD or as median [IQR]. p < 0.05